AMGN TEZSPIRE® reports positive Phase 3 results in eosinophilic esophagitis
AMGN says its TEZSPIRE® showed positive Phase 3 results across the co-primary and all key secondary endpoints in eosinophilic esophagitis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.